IGFBP7 and hydrops fetalis: From a clinical standpoint, the circulating levels of IGFBP7 are increased in patients suffering from HF, are associated with diastolic function in HF patients with either normal or reduced ejection fraction [20,21,22], and predict risk for hospitalisation or death and renal outcomes [32].